# LMBR1L

## Overview
The LMBR1L gene encodes the limb development membrane protein 1-like, a transmembrane protein that plays a critical role in cellular signaling, particularly within the Wnt/β-catenin pathway. This protein is characterized by its nine transmembrane-spanning domains and is predominantly located in the endoplasmic reticulum, where it is involved in the maturation and regulation of Wnt co-receptors (Gyimesi2022Systematic; Choi2019LMBR1L). LMBR1L functions as a negative regulator of the Wnt/β-catenin signaling pathway, crucial for lymphopoiesis and immune cell function, by stabilizing the β-catenin destruction complex and promoting β-catenin degradation (Choi2019LMBR1L). The gene's significance extends to clinical implications, where mutations have been linked to various conditions, including lymphocyte development disorders and certain cancers (Soh2023Lymphoma; Kumari2021The).

## Structure
The LMBR1L protein is characterized by having nine transmembrane-spanning domains, which are most abundant in the endoplasmic reticulum (ER) fraction (Choi2019LMBR1L). These transmembrane domains suggest a significant role in cellular signaling and transport functions, although the exact tertiary structure remains unknown (Gyimesi2022Systematic). The protein is homologous to lipocalin membrane receptors and is known to bind lipocalin 1 (LCN-1) with high affinity (Gyimesi2022Systematic).

In dogs, the LMBR1L gene gives rise to two isoforms, X1 and X2, through alternative splicing. The X2 isoform is longer, containing an additional 127 amino acids at the N-terminus due to the inclusion of exon 3, which is absent in the X1 isoform. The X2 isoform has nine transmembrane domains and is expressed in the ER and plasma membrane, while the X1 isoform lacks these additional amino acids, including parts of the transmembrane domains (Lourdes2023Autosomal). The specific functional differences between these isoforms in humans are not well characterized, but they may have distinct roles in cellular processes (Lourdes2023Autosomal).

## Function
The LMBR1L gene encodes a transmembrane protein that plays a crucial role in regulating the Wnt/β-catenin signaling pathway, which is essential for lymphopoiesis and immune cell function. In healthy human cells, LMBR1L acts as a negative regulator of this pathway by stabilizing the β-catenin destruction complex, thereby promoting the degradation of β-catenin and preventing its accumulation in the nucleus (Choi2019LMBR1L). This regulation is vital for maintaining proper levels of Wnt signaling, which is critical for the survival, renewal, and differentiation of hematopoietic stem cells into lymphoid lineages (Choi2019LMBR1L).

LMBR1L is also involved in the maturation of Wnt co-receptors within the endoplasmic reticulum (ER), affecting the localization and stability of components like FZD6 and LRP6 (Choi2019LMBR1L). The protein forms a complex with GP78 and UBAC2, which regulates the ubiquitination and degradation of β-catenin, further influencing Wnt signaling (Choi2019LMBR1L). In the absence of LMBR1L, there is an aberrant activation of Wnt/β-catenin signaling, leading to increased apoptosis and impaired lymphocyte development (Choi2019LMBR1L). This suggests that LMBR1L is essential for the proper maturation and function of lymphocytes, highlighting its importance in immune system development (Choi2019LMBR1L).

## Clinical Significance
Mutations and alterations in the LMBR1L gene have been implicated in various conditions, primarily through its role in the Wnt/β-catenin signaling pathway. In mice, mutations in LMBR1L have been linked to impaired lymphocyte development, as the gene appears to act as a negative regulator of Wnt/β-catenin signaling. This regulation is crucial for maintaining normal levels of proteins in the β-catenin destruction complex, and disruptions can lead to increased levels of β-catenin and associated proteins, potentially contributing to conditions like certain cancers, Alzheimer's disease, cardiovascular diseases, and schizophrenia (Kumari2021The).

In dogs, particularly Australian Shepherds, a splice site variant in LMBR1L is associated with autosomal recessive hyposegmentation of granulocytes (HG), a condition similar to Pelger-Huet anomaly in humans. This variant affects the expression of the LMBR1L protein isoforms, leading to the HG phenotype, although it does not appear to have negative health consequences (Lourdes2023Autosomal).

In Border Collies, LMBR1L has been identified as a candidate gene in the context of lymphoma, with significant SNPs associated with the disease, suggesting a potential role in lymphocyte development and immune system conditions (Soh2023Lymphoma).

## Interactions
The LMBR1L gene encodes a protein that plays a significant role in lymphopoiesis by modulating the Wnt/β-catenin signaling pathway. LMBR1L is known to interact with several proteins, forming complexes that influence cellular processes. It acts as a negative regulator of the Wnt/β-catenin signaling pathway by interacting with components such as GSK-3β, β-catenin, and LRP6. These interactions have been confirmed through co-immunoprecipitation and mass spectrometry analyses, as well as protein microarray studies (Choi2019LMBR1L).

LMBR1L is also a part of the GP78-UBAC2 ubiquitin ligase complex, which regulates the maturation of Wnt receptors within the endoplasmic reticulum. This complex includes proteins like UBAC2, TERA, UBXD8, and GP78, and is involved in the ubiquitination and degradation of Wnt receptors, thereby controlling Wnt signaling (Choi2019LMBR1L). The interaction between LMBR1L and these proteins suggests its role in stabilizing GSK-3β and regulating β-catenin levels, which are crucial for proper lymphocyte development and function (Choi2019LMBR1L).


## References


[1. (Soh2023Lymphoma) Pamela Xing Yi Soh, Mehar Singh Khatkar, and Peter Williamson. Lymphoma in border collies: genome-wide association and pedigree analysis. Veterinary Sciences, 10(9):581, September 2023. URL: http://dx.doi.org/10.3390/vetsci10090581, doi:10.3390/vetsci10090581. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/vetsci10090581)

[2. (Choi2019LMBR1L) Jin Huk Choi, Xue Zhong, William McAlpine, Tzu-Chieh Liao, Duanwu Zhang, Beibei Fang, Jamie Russell, Sara Ludwig, Evan Nair-Gill, Zhao Zhang, Kuan-wen Wang, Takuma Misawa, Xiaoming Zhan, Mihwa Choi, Tao Wang, Xiaohong Li, Miao Tang, Qihua Sun, Liyang Yu, Anne R. Murray, Eva Marie Y. Moresco, and Bruce Beutler. Lmbr1l regulates lymphopoiesis through wnt/β-catenin signaling. Science, May 2019. URL: http://dx.doi.org/10.1126/science.aau0812, doi:10.1126/science.aau0812. This article has 44 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.aau0812)

[3. (Lourdes2023Autosomal) Bianca Lourdes Frehner, Matthias Christen, Iris M. Reichler, Vidhya Jagannathan, Marilisa Novacco, Barbara Riond, Laureen M. Peters, José Suárez Sánchez-Andrade, Aldona Pieńkowska-Schelling, Claude Schelling, Anja Kipar, Tosso Leeb, and Orsolya Balogh. Autosomal recessive hyposegmentation of granulocytes in australian shepherd dogs indicates a role for lmbr1l in myeloid leukocytes. PLOS Genetics, 19(6):e1010805, June 2023. URL: http://dx.doi.org/10.1371/journal.pgen.1010805, doi:10.1371/journal.pgen.1010805. This article has 3 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1010805)

[4. (Gyimesi2022Systematic) Gergely Gyimesi and Matthias A. Hediger. Systematic in silico discovery of novel solute carrier-like proteins from proteomes. PLOS ONE, 17(7):e0271062, July 2022. URL: http://dx.doi.org/10.1371/journal.pone.0271062, doi:10.1371/journal.pone.0271062. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0271062)

[5. (Kumari2021The) Deepa Kumari and Jeffrey L. Brodsky. The targeting of native proteins to the endoplasmic reticulum-associated degradation (erad) pathway: an expanding repertoire of regulated substrates. Biomolecules, 11(8):1185, August 2021. URL: http://dx.doi.org/10.3390/biom11081185, doi:10.3390/biom11081185. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom11081185)